Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Stephen E. Henrich & C. Shad Thaxton. (2019) An update on synthetic high-density lipoprotein-like nanoparticles for cancer therapy. Expert Review of Anticancer Therapy 19:6, pages 515-528.
Read now
Read now
Parasuraman Aiya Subramani, Kalpana Panati & Venkata Ramireddy Narala. (2017) Curcumin Nanotechnologies and Its Anticancer Activity. Nutrition and Cancer 69:3, pages 381-393.
Read now
Read now
Heng-Fei Du, Lu-Jia Yu, Yan-Feng Meng, Hong-Yan Lv, Jianbo Meng, Xiao-Ning Song & Jin-Qiao Zhang. (2013) Norcantharidin enhances bortezomib-antimyeloma activity in multiple myeloma cells in vitro and in nude mouse xenografts. Leukemia & Lymphoma 54:3, pages 607-618.
Read now
Read now
Tamar Tadmor & Aaron Polliack. (2011) Mantle cell lymphoma: curcumin nanodisks and possible new concepts on drug delivery for an incurable lymphoma. Leukemia & Lymphoma 52:8, pages 1418-1420.
Read now
Read now
Articles from other publishers (37)
Ahmed O. Elzoghby, Omar Samir, Ahmed Soliman, Sergey Solomevich, Minzhi Yu, Anna Schwendeman & Mahmoud L. Nasr. (2023) Nanodiscs: Game changer nano-therapeutics and structural biology tools. Nano Today 53, pages 102026.
Crossref
Crossref
Mohsen Rahmanian, Fatemeh Oroojalian, Elham Pishavar, Prashant Kesharwani & Amirhossein Sahebkar. (2023) Nanogels, nanodiscs, yeast cells, and metallo-complexes-based curcumin delivery for therapeutic applications. European Polymer Journal 196, pages 112215.
Crossref
Crossref
Salar Hafez Ghoran, Andrea Calcaterra, Milad Abbasi, Fatemeh Taktaz, Kay Nieselt & Esmaeil Babaei. (2022) Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment. Molecules 27:16, pages 5236.
Crossref
Crossref
Caroline R Garcia, Armin T Rad, Farnoosh Saeedinejad, Arvind Manojkumar, Deepa Roy, Hansapani Rodrigo, Sue Anne Chew, Ziyaur Rahman, Mu-Ping Nieh & Upal Roy. (2022) Effect of drug-to-lipid ratio on nanodisc-based tenofovir drug delivery to the brain for HIV-1 infection. Nanomedicine 17:13, pages 959-978.
Crossref
Crossref
Jitender Bariwal, Hairong Ma, Guillermo A. Altenberg & Hongjun Liang. (2022) Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment. Chemical Society Reviews 51:5, pages 1702-1728.
Crossref
Crossref
Sicong Wang, Giovanna Di Trapani & Kathryn F. Tonissen. (2022) Expanding the armory for treating lymphoma: Targeting redox cellular status through thioredoxin reductase inhibition. Pharmacological Research 177, pages 106134.
Crossref
Crossref
Colin A. Fox, Anthony Moschetti & Robert O. Ryan. (2021) Reconstituted HDL as a therapeutic delivery device. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1866:11, pages 159025.
Crossref
Crossref
Md. Tanvir Kabir, Md. Habibur Rahman, Rokeya Akter, Tapan Behl, Deepak Kaushik, Vineet Mittal, Parijat Pandey, Muhammad Furqan Akhtar, Ammara Saleem, Ghadeer M. Albadrani, Mohamed Kamel, Shaden A.M. Khalifa, Hesham R. El-Seedi & Mohamed M. Abdel-Daim. (2021) Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers. Biomolecules 11:3, pages 392.
Crossref
Crossref
Durdana Yasin, Md Zafaryab, Khalid Umar Fakhri, Shaheen Husain, Bushra Afzal, Neha Sami, Hemlata Hemlata, M. Moshahid Alam Rizvi & Tasneem Fatma. 2021. Handbook of Research on Advancements in Cancer Therapeutics. Handbook of Research on Advancements in Cancer Therapeutics
290
311
.
Dennis Pedersbæk & Jens B. Simonsen. (2020) A systematic review of the biodistribution of biomimetic high-density lipoproteins in mice. Journal of Controlled Release 328, pages 792-804.
Crossref
Crossref
Saleh A. Alanazi, Fars Alanazi, Nazrul Haq, Faiyaz Shakeel, Mohamed M. Badran & Gamaleldin I. Harisa. (2020) Lipoproteins-Nanocarriers as a Promising Approach for Targeting Liver Cancer: Present Status and Application Prospects. Current Drug Delivery 17:10, pages 826-844.
Crossref
Crossref
Skylar T. Chuang, Siobanth Cruz & Vasanthy Narayanaswami. (2020) Reconfiguring Nature’s Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents. Nanomaterials 10:5, pages 906.
Crossref
Crossref
Adhimoolam Karthikeyan, Natesan Senthil & Taesun Min. (2020) Nanocurcumin: A Promising Candidate for Therapeutic Applications. Frontiers in Pharmacology 11.
Crossref
Crossref
David Castaño, Chutima Rattanasopa, Vera F. Monteiro-Cardoso, Maria Corlianò, Yiran Liu, Shiqi Zhong, Mihaela Rusu, Elisa A. Liehn & Roshni R. Singaraja. (2020) Lipid efflux mechanisms, relation to disease and potential therapeutic aspects. Advanced Drug Delivery Reviews 159, pages 54-93.
Crossref
Crossref
Maricruz Anaya-Ruiz, Cindy Bandala, Gerardo Landeta, Patricia Martínez-Morales, Jose L. Zumaquero-Rios, Jorge Sarracent-Pérez & Martín Pérez-Santos. (2019) Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents. Recent Patents on Anti-Cancer Drug Discovery 14:1, pages 85-94.
Crossref
Crossref
Maki Tsujita, Anna Wolska, Daniel A.P. Gutmann & Alan T. Remaley. (2018) Reconstituted Discoidal High-Density Lipoproteins: Bioinspired Nanodiscs with Many Unexpected Applications. Current Atherosclerosis Reports 20:12.
Crossref
Crossref
Piming Zhao, Ana E. Aguilar, Joanna Y. Lee, Lucy A. Paul, Jung H. Suh, Latika Puri, Meng Zhang, Jennifer Beckstead, Andrzej Witkowski, Robert O. Ryan & Julie D. Saba. (2018) Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway. Investigational New Drugs 36:5, pages 743-754.
Crossref
Crossref
Sangram Raut, Jean-Louis Dasseux, Nirupama A Sabnis, Linda Mooberry & Andras Lacko. (2018) Lipoproteins for therapeutic delivery: recent advances and future opportunities. Therapeutic Delivery 9:4, pages 257-268.
Crossref
Crossref
Claire Pfeffer & Amareshwar Singh. (2018) Apoptosis: A Target for Anticancer Therapy. International Journal of Molecular Sciences 19:2, pages 448.
Crossref
Crossref
Xinyi Ma, Qingxiang Song & Xiaoling Gao. (2018) Reconstituted high-density lipoproteins: novel biomimetic nanocarriers for drug delivery. Acta Pharmaceutica Sinica B 8:1, pages 51-63.
Crossref
Crossref
Jens B. Simonsen. (2016) Evaluation of reconstituted high-density lipoprotein (rHDL) as a drug delivery platform – a detailed survey of rHDL particles ranging from biophysical properties to clinical implications. Nanomedicine: Nanotechnology, Biology and Medicine 12:7, pages 2161-2179.
Crossref
Crossref
Makhdum Ahmed, Leo Zhang, Krystle Nomie, Laura Lam & Michael Wang. (2016) Gene mutations and actionable genetic lesions in mantle cell lymphoma. Oncotarget 7:36, pages 58638-58648.
Crossref
Crossref
Rui Kuai, Dan Li, Y. Eugene Chen, James J. Moon & Anna Schwendeman. (2016) High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles. ACS Nano 10:3, pages 3015-3041.
Crossref
Crossref
R. Kannan Mutharasan, Linda Foit & C. Shad Thaxton. (2016) High-density lipoproteins for therapeutic delivery systems. Journal of Materials Chemistry B 4:2, pages 188-197.
Crossref
Crossref
Natasha M. CrosbyMistuni GhoshBetty SuJennifer A. BecksteadAyako KameiJens B. SimonsenBing LuoLeo I. GordonTrudy M. ForteRobert O. Ryan. (2015) Anti-CD20 single chain variable antibody fragment–apolipoprotein A-I chimera containing nanodisks promote targeted bioactive agent delivery to CD20-positive lymphomas. Biochemistry and Cell Biology 93:4, pages 343-350.
Crossref
Crossref
Huang Huang, William Cruz, Juan Chen & Gang Zheng. (2014) Learning from biology: synthetic lipoproteins for drug delivery. WIREs Nanomedicine and Nanobiotechnology 7:3, pages 298-314.
Crossref
Crossref
Kaylin M. McMahon, Linda Foit, Nicholas L. Angeloni, Francis J. Giles, Leo I. Gordon & C. Shad Thaxton. 2015. Nanotechnology-Based Precision Tools for the Detection and Treatment of Cancer. Nanotechnology-Based Precision Tools for the Detection and Treatment of Cancer
129
150
.
Mistuni Ghosh & Robert O. Ryan. (2014) Curcumin homing to the nucleolus: mechanism for initiation of an apoptotic program. The Journal of Nutritional Biochemistry 25:11, pages 1117-1123.
Crossref
Crossref
Emmanouil Nikolousis. 2014. Horizons in Clinical Nanomedicine. Horizons in Clinical Nanomedicine
93
113
.
JINGJING WU, QIN TANG, SHUNYU ZHAO, FANG ZHENG, YAN WU, GE TANG & SWEI SUNNY HAHN. (2014) Extracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin. International Journal of Oncology 45:1, pages 95-103.
Crossref
Crossref
Mistuni Ghosh & Robert O Ryan. (2014) ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells. Nanomedicine 9:6, pages 763-771.
Crossref
Crossref
Xuanbin Wang, Yibin Feng, Ning Wang, Fan Cheung, Hor Yue Tan, Sen Zhong, Charlie Li & Seiichi Kobayashi. (2014) Chinese Medicines Induce Cell Death: The Molecular and Cellular Mechanisms for Cancer Therapy. BioMed Research International 2014, pages 1-14.
Crossref
Crossref
Urszula Lewandowska, Karolina Szewczyk, Elżbieta Hrabec, Anna Janecka & Sylwia Gorlach. (2013) Overview of Metabolism and Bioavailability Enhancement of Polyphenols. Journal of Agricultural and Food Chemistry 61:50, pages 12183-12199.
Crossref
Crossref
Marina G. Damiano, R. Kannan Mutharasan, Sushant Tripathy, Kaylin M. McMahon & C. Shad Thaxton. (2013) Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery. Advanced Drug Delivery Reviews 65:5, pages 649-662.
Crossref
Crossref
Stefanie KewitzInes VolkmerMartin S. Staege. (2013) Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma. Cancer Growth and Metastasis 6, pages CGM.S11113.
Crossref
Crossref
Zainul Hasanali, Kamal Sharma & Elliot Epner. (2012) Flipping the cyclin D1 switch in mantle cell lymphoma. Best Practice & Research Clinical Haematology 25:2, pages 143-152.
Crossref
Crossref
Xiuzhen Han, Baoshan Xu, Christopher S. Beevers, Yoshinobu Odaka, Long Chen, Lei Liu, Yan Luo, Hongyu Zhou, Wenxing Chen, Tao Shen & Shile Huang. (2012) Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells. Carcinogenesis 33:4, pages 868-875.
Crossref
Crossref